Jostein Dahle

Publications by Jostein Dahle

31 publications found

Publications 2012

1. Kalanxhi E, Dahle J (2012)
   Genome-wide microarray analysis of human fibroblasts in response to ? radiation and the radiation-induced bystander effect
   Radiat Res, 177 (1), 35-43
   PubMed 22034846

Publications 2011

1. Abbas N, Heyerdahl H, Bruland OS, Borrebæk J, Nesland J, Dahle J (2011)
   Experimental ?-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab
   EJNMMI Res, 1 (1), 18
   PubMed 22214432
2. Dahle J, Abbas N, Bruland ØS, Larsen RH (2011)
   Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates
   Curr Radiopharm, 4 (4), 321-8
   PubMed 22202154
3. Dahle J, Kalanxhi E, Tisnek N (2011)
   Dosimetry of a 238Pu-based alpha-particle irradiator and its biological application in a study of the bystander effect
   Anticancer Res, 31 (6), 2113-20
   PubMed 21737630
4. Heyerdahl H, Krogh C, Borrebæk J, Larsen Å, Dahle J (2011)
   Treatment of HER2-expressing breast cancer and ovarian cancer cells with alpha particle-emitting 227Th-trastuzumab
   Int J Radiat Oncol Biol Phys, 79 (2), 563-70
   PubMed 21195878

Publications 2010

1. Dahle J, Jonasdottir TJ, Heyerdahl H, Nesland JM, Borrebaek J, Hjelmerud AK, Larsen RH (2010)
   Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate (227)Th-rituximab
   Eur J Nucl Med Mol Imaging, 37 (1), 93-102
   PubMed 19593562

Publications 2009

1. Dahle J, Krogh C, Melhus KB, Borrebaek J, Larsen RH, Kvinnsland Y (2009)
   In vitro cytotoxicity of low-dose-rate radioimmunotherapy by the alpha-emitting radioimmunoconjugate Thorium-227-DOTA-rituximab
   Int J Radiat Oncol Biol Phys, 75 (3), 886-95
   PubMed 19679402
2. Tisnek N, Kalanxhi E, Serkland CW, Iversen J, Belyakov OV, Dahle J (2009)
   A (238)Pu irradiator for exposure of cultured cells with alpha-radiation: construction, calibration and dosimetry
   Appl Radiat Isot, 67 (11), 1998-2002
   PubMed 19716308

Publications 2008

1. Dahle J, Bruland OS, Larsen RH (2008)
   Relative biologic effects of low-dose-rate alpha-emitting 227Th-rituximab and beta-emitting 90Y-tiuexetan-ibritumomab versus external beam X-radiation
   Int J Radiat Oncol Biol Phys, 72 (1), 186-92
   PubMed 18722269
2. Dahle J, Brunborg G, Svendsrud DH, Stokke T, Kvam E (2008)
   Overexpression of human OGG1 in mammalian cells decreases ultraviolet A induced mutagenesis
   Cancer Lett, 267 (1), 18-25
   PubMed 18406515

Publications 2007

1. Dahle J, Borrebaek J, Jonasdottir TJ, Hjelmerud AK, Melhus KB, Bruland ØS, Press OW, Larsen RH (2007)
   Targeted cancer therapy with a novel low-dose rate alpha-emitting radioimmunoconjugate
   Blood, 110 (6), 2049-56
   PubMed 17536011
2. Dahle J, Krogh C, Melhus KB, Kaalhus O, Larsen RH, Stokke T (2007)
   A one-step method for determining the maximum number of bound antibodies, and the affinity and association rate constants for antibody binding
   Nucl Med Commun, 28 (9), 742-7
   PubMed 17667754
3. Larsen RH, Borrebaek J, Dahle J, Melhus KB, Krogh C, Valan MH, Bruland OS (2007)
   Preparation of TH227-labeled radioimmunoconjugates, assessment of serum stability and antigen binding ability
   Cancer Biother Radiopharm, 22 (3), 431-7
   PubMed 17651051
4. Melhus KB, Larsen RH, Stokke T, Kaalhus O, Selbo PK, Dahle J (2007)
   Evaluation of the binding of radiolabeled rituximab to CD20-positive lymphoma cells: an in vitro feasibility study concerning low-dose-rate radioimmunotherapy with the alpha-emitter 227Th
   Cancer Biother Radiopharm, 22 (4), 469-79
   PubMed 17803441

Publications 2006

1. Dahle J, Borrebaek J, Melhus KB, Bruland OS, Salberg G, Olsen DR, Larsen RH (2006)
   Initial evaluation of (227)Th-p-benzyl-DOTA-rituximab for low-dose rate alpha-particle radioimmunotherapy
   Nucl Med Biol, 33 (2), 271-9
   PubMed 16546683

Publications 2005

1. Dahle J, Kvam E, Stokke T (2005)
   Bystander effects in UV-induced genomic instability: antioxidants inhibit delayed mutagenesis induced by ultraviolet A and B radiation
   J Carcinog, 4, 11
   PubMed 16091149
2. Dahle J, Kaalhus O, Stokke T, Kvam E (2005)
   Bystander effects may modulate ultraviolet A and B radiation-induced delayed mutagenesis
   Radiat Res, 163 (3), 289-95
   PubMed 15733036
3. Dahle J, Noordhuis P, Stokke T, Svendsrud DH, Kvam E (2005)
   Multiplex polymerase chain reaction analysis of UV-A- and UV-B-induced delayed and early mutations in V79 Chinese hamster cells
   Photochem Photobiol, 81 (1), 114-9
   PubMed 15453821
4. Kvam E, Dahle J (2005)
   The pheomelanin precursor 5-S-cysteinyldopa protects melanocytes from membrane damage induced by ultraviolet A radiation
   Cancer Lett, 221 (2), 131-4
   PubMed 15808398

Publications 2004

1. Dahle J, Kakar M, Steen HB, Kaalhus O (2004)
   Automated counting of mammalian cell colonies by means of a flat bed scanner and image processing
   Cytometry A, 60 (2), 182-8
   PubMed 15290719
2. Dahle J, Kvam E (2004)
   Increased level of oxidative stress in genomically unstable cell clones
   J Photochem Photobiol B, 74 (1), 23-8
   PubMed 15043843
3. Kvam E, Dahle J (2004)
   Melanin synthesis may sensitize melanocytes to oxidative DNA damage by ultraviolet A radiation and protect melanocytes from direct DNA damage by ultraviolet B radiation
   Pigment Cell Res, 17 (5), 549-50
   PubMed 15357843

Publications 2003

1. Dahle J, Kvam E (2003)
   Induction of delayed mutations and chromosomal instability in fibroblasts after UVA-, UVB-, and X-radiation
   Cancer Res, 63 (7), 1464-9
   PubMed 12670891
2. Kvam E, Dahle J (2003)
   Pigmented melanocytes are protected against ultraviolet-A-induced membrane damage
   J Invest Dermatol, 121 (3), 564-9
   PubMed 12925216

Publications 2001

1. Dahle J, Angell-Petersen E, Steen HB, Moan J (2001)
   Bystander effects in cell death induced by photodynamic treatment UVA radiation and inhibitors of ATP synthesis
   Photochem Photobiol, 73 (4), 378-87
   PubMed 11332033

Publications 2000

1. Dahle J, Bagdonas S, Kaalhus O, Olsen G, Steen HB, Moan J (2000)
   The bystander effect in photodynamic inactivation of cells
   Biochim Biophys Acta, 1475 (3), 273-80
   PubMed 10913826
2. Dahle J, Mikalsen SO, Rivedal E, Steen HB (2000)
   Gap junctional intercellular communication is not a major mediator in the bystander effect in photodynamic treatment of MDCK II cells
   Radiat Res, 154 (3), 331-41
   PubMed 10956441

Publications 1999

1. Bagdonas S, Dahle J, Kaalhus O, Moan J (1999)
   Cooperative inactivation of cells in microcolonies treated with UVA radiation
   Radiat Res, 152 (2), 174-9
   PubMed 10409327
2. Dahle J, Angel-Petersen E, Bagdonas S, Steen HB, Moan J (1999)
   Cooperative effects of photosensitized cell killing
   P SOC PHOTO-OPT INS, 3563, 120-124
3. Dahle J, Steen HB, Moan J (1999)
   The mode of cell death induced by photodynamic treatment depends on cell density
   Photochem Photobiol, 70 (3), 363-7
   PubMed 10483366

Publications 1997

1. Dahle J, Kaalhus O, Moan J, Steen HB (1997)
   Cooperative effects of photodynamic treatment of cells in microcolonies
   Proc Natl Acad Sci U S A, 94 (5), 1773-8
   PubMed 9050854